Bernard Coulie Sells 35,339 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX) Stock

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) CEO Bernard Coulie sold 35,339 shares of the stock in a transaction dated Thursday, March 30th. The stock was sold at an average price of $26.52, for a total value of $937,190.28. Following the sale, the chief executive officer now owns 274,753 shares of the company’s stock, valued […]

Related Keywords

United States ,Bernard Coulie ,Stifel Nicolaus ,Pliant Therapeutics Inc ,Citigroup ,Bessemer Group Inc ,Securities Exchange Commission ,Management Company Inc ,Quantamental Technologies ,Delphia United States Inc ,Nasdaq ,Pliant Therapeutics Company Profile ,Blackstone Inc ,Pliant Therapeutics ,Get Rating ,Exchange Commission ,Therapeutics Stock Down ,Bessemer Group ,Pliant Therapeutics Daily ,Nasdaq Plrx ,Plrx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,